ENDOXOS LIMITED

Company Registration Number:
13675330 (England and Wales)

Unaudited micro entity accounts for the year ended 31 October 2024

Period of accounts

Start date: 01 November 2023

End date: 31 October 2024

ENDOXOS LIMITED

Contents of the Financial Statements

for the Period Ended 31 October 2024

Company Information - 3
Profit and Loss Account - 4
Balance sheet - 5
Footnotes to the Balance Sheet - 7

ENDOXOS LIMITED

Company Information

for the Period Ended 31 October 2024




Registered office: 124
City Road
London
England
EC1V 2NX
Company Registration Number: 13675330 (England and Wales)

ENDOXOS LIMITED

Profit and Loss Account

for the Period Ended 31 October 2024


2024
£

2023
£
Turnover 383,368 249,814
Cost of Materials ( 389,528 ) ( 94,551 )
Staff Costs - ( 588 )
Other charges ( 4,041 ) ( 146,504 )
Tax on Profit ( 0 ) ( 1,552 )
Profit or (Loss) for Period ( 10,201 ) 6,619

ENDOXOS LIMITED

Balance sheet

As at 31 October 2024


2024
£

2023
£
Called up share capital not paid: 0 0
Fixed Assets: 0 0
Current assets: 89,494 65,396
Prepayments and accrued income: 0 0
Creditors: amounts falling due within one year: ( 82,186 ) ( 47,887 )
Net current assets (liabilities): 7,308 17,509
Total assets less current liabilities: 7,308 17,509
Creditors: amounts falling due after more than one year: ( 0 ) ( 0 )
Provision for liabilities: ( 0 ) ( 0 )
Accruals and deferred income: ( 0 ) ( 0 )
Total net assets (liabilities): 7,308 17,509
Capital and reserves: 7,308 17,509

ENDOXOS LIMITED

Balance sheet continued

For the year ending 31 October 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 30 September 2025
And Signed On Behalf Of The Board By:

Name: Angelo Angelucci
Status: Director

The notes form part of these financial statements

ENDOXOS LIMITED

Footnotes to the Financial Statements

for the Period Ended 31 October 2024

  • 1. Employee Information

    Average number of employees: 0

ENDOXOS LIMITED

Footnotes to the Financial Statements

for the Period Ended 31 October 2024

  • 2. Off balance sheet disclosure

    No